|
| | Publication Year | Title | Author(s) |
| 541 | 29-Jun-2023 | Nurse-led emergency department avoidance model of care for patients receiving cancer therapy in the ambulatory setting: a health service improvement initiative. | Mellerick, Angela ; Akers, Georgina; Tebbutt, Niall C ; Lane, Tyler; Jarden, Rebecca J. ; Whitfield, Kathryn |
| 542 | 14-Nov-2017 | Nurses attitudes and practices towards provision of survivorship care for people with a haematological cancer on completion of treatment | Chan, Raymond Javan; Button, Elise; Thomas, Alison; Gates, Priscilla ; Yates, Patsy |
| 543 | 2023 | NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma. | Sim, Hao-Wen; Wachsmuth, Luke; Barnes, Elizabeth H; Yip, Sonia; Koh, Eng-Siew; Hall, Merryn; Jennens, Ross; Ashley, David M; Verhaak, Roel G; Heimberger, Amy B; Rosenthal, Mark A; Hovey, Elizabeth J; Ellingson, Benjamin M; Tognela, Annette; Gan, Hui K ; Wheeler, Helen; Back, Michael; McDonald, Kerrie L; Long, Anne; Cuff, Katharine; Begbie, Stephen; Gedye, Craig; Mislang, Anna; Le, Hien; Johnson, Margaret O; Kong, Benjamin Y; Simes, John R; Lwin, Zarnie; Khasraw, Mustafa |
| 544 | Jul-2023 | Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study. | Townsend, William; Hiddemann, Wolfgang; Buske, Christian; Cartron, Guillaume; Cunningham, David; Dyer, Martin J S; Gribben, John G; Phillips, Elizabeth H; Dreyling, Martin; Seymour, John F; Grigg, Andrew P ; Trotman, Judith; Lin, Tong-Yu; Hong, Xiao-Nan; Kingbiel, Dirk; Nielsen, Tina G; Knapp, Andrea; Herold, Michael; Marcus, Robert |
| 545 | Mar-2020 | Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report. | Gunjur, Ashray ; Chong, Geoffrey ; Lim, Adeline ; Lau, Eddie ; Mitchell, Paul L R ; John, Thomas ; Arulananda, Surein |
| 546 | 2022 | Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study. | Evens, Andrew M; Connors, Joseph M; Younes, Anas; Ansell, Stephen M; Kim, Won Seog; Radford, John; Feldman, Tatyana; Tuscano, Joseph; Savage, Kerry J; Oki, Yasuhiro; Grigg, Andrew P ; Pocock, Christopher; Dlugosz-Danecka, Monika; Fenton, Keenan; Forero-Torres, Andres; Liu, Rachael; Jolin, Hina; Gautam, Ashish; Gallamini, Andrea |
| 547 | 2023 | Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: a multicenter, open-label, phase 1b/2 trial. | de la Fuente, Macarena I; Colman, Howard; Rosenthal, Mark; Van Tine, Brian A; Levacic, Danijela; Walbert, Tobias; Gan, Hui K ; Vieito, Maria; Milhem, Mohammed M; Lipford, Kathryn; Forsyth, Sanjeev; Guichard, Sylvie M; Mikhailov, Yelena; Sedkov, Alexander; Brevard, Julie; Kelly, Patrick F; Mohamed, Hesham; Monga, Varun |
| 548 | Jul-2024 | Oncology antimicrobial stewardship: safe intravenous-to-oral switch and antimicrobial optimisation (OASSIS) | Urbancic, Karen F ; Batrouney, Adele; Yeo, Belinda ; Tebbutt, Niall C ; Smibert, Olivia C ; Trubiano, Jason ; Reynolds, Gemma K |
| 549 | Oct-2020 | Optimal oral cyclosporin dosing with concomitant posaconazole post allogeneic stem cell transplantation. | Robinson, Danielle H ; Hughes, Charlotte F M; Grigg, Andrew P |
| 550 | 24-Jul-2018 | Optimal Treatment for High-Risk Prostate Cancer. | Ong, Wee Loon ; Koh, Tze Lui; Millar, Jeremy |
| 551 | 26-Mar-2024 | Optimising Patient Outcomes in Tongue Cancer: A Multidisciplinary Approach | de Boer, Jasper; Barnett, Rebecca; Cardin, Anthony; Cimoli, Michelle ; Davies, Lauren; Delany, Clare; Dixon, Benjamin J; Evans, Sue M; Findlay, Michael W; Fox, Carly; Ftanou, Maria; Hart, Christopher D; Howard, Megan; Iseli, Tim A; Jackson, Andrea; Kranz, Sevastjan; Le, Brian H; Lekgabe, Ernest; Lennox, Rachel; McLean, Luke S; Neeson, Paul J; Ng, Sweet Ping ; O'Reilly, Lorraine A; Ramakrishnan, Anand; Rowe, David; Service, Carrie; Singh, Ankur; Thai, Alesha A; Tiong, Albert; Yap, Tami; Wiesenfeld, David |
| 552 | Nov-2020 | Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer. | de Boer, Richard; Hui, Rina; Lim, Elgene; Yeo, Belinda ; Zdenkowski, Nicholas |
| 553 | Feb-2023 | Optimizing the oral dose of cyclosporine with concomitant posaconazole post stem cell allograft. | McClelland, Julia; Wong, Eric ; Grigg, Andrew P |
| 554 | 28-Jul-2017 | Oral versus intravenous fluoropyrimidines for colorectal cancer | Chionh, Fiona; Lau, David; Yeung, Yvonne; Price, Timothy; Tebbutt, Niall C |
| 555 | Apr-2019 | Osimertinib as first-line (1L) treatment for epidermal growth factor receptor (EGFR) mutation-positive advanced non-small cell lung cancer (NSCLC): Final efficacy and safety results from two phase I expansion cohorts. | Yang, J C-H; Ramalingam, S S; Lee, C K; Kurata, T; Kim, D-W; John, Thomas ; Nogami, N; Ohe, Y; Rukazenkov, Y; Murphy, M; Jänne, P A |
| 556 | 2018 | Osimertinib as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer | Ramalingam, Suresh S; Yang, James C-H; Lee, Chee Khoon; John, Thomas ; Kurata, Takayasu; Nogami, Naoyuki; Ohe, Yuichiro; Kim, Dong-Wan; Mann, Helen; Rukazenkov, Yuri; Ghiorghiu, Serban; Stetson, Daniel; Markovets, Aleksandra; Barrett, J Carl; Thress, Kenneth S; Jänne, Pasi A |
| 557 | Oct-2020 | Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer. | Wu, Yi-Long; Tsuboi, Masahiro; He, Jie; John, Thomas ; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu-Vinh; Lu, Shun; Lee, Kye-Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Hodge, Rachel; Atasoy, Ajlan; Rukazenkov, Yuri; Herbst, Roy S |
| 558 | Nov-2020 | Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis. | Papadimitrakopoulou, V A; Mok, T S; Han, J-Y; Ahn, M-J; Delmonte, A; Ramalingam, S S; Kim, S W; Shepherd, F A; Laskin, J; He, Y; Akamatsu, H; Theelen, W S M E; Su, W-C; John, Thomas ; Sebastian, M; Mann, H; Miranda, M; Laus, G; Rukazenkov, Y; Wu, Y-L |
| 559 | Aug-2023 | Outcome of an elective readmission policy in patients receiving acute myeloid leukaemia consolidation therapy and implications for an outpatient management programme. | Grigg, Andrew P ; Prabahran, Ashvind; Donati, Vanessa; Wong, Eric ; Mason, Kate |
| 560 | 1-Jul-2017 | Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial. | Kühnl, A; Cunningham, D; Counsell, Nicholas; Hawkes, Eliza A ; Qian, W; Smith, P; Chadwick, N; Lawrie, A; Mouncey, P; Jack, A; Pocock, C; Ardeshna, Kirit M; Radford, J; McMillan, A; Davies, J; Turner, D; Kruger, A; Johnson, P W; Gambell, J; Rosenwald, A; Ott, G; Horn, H; Ziepert, M; Pfreundschuh, M; Linch, D |
